“Promising” stem cell therapy for hair loss could be available in five years

Researchers at the San Carlos clinical hospital in Madrid may have targeted a potential solution for hair loss.

A recent study has analyzed the effect of the injection of the skin of the mouse with stem cells of human fat – “stem cells derived from adipone (ASC)” – as a means of treating androgenetic alopecia (AGA), more commonly known as male or female hair loss.

The team noted that male mice had made the best hair regrowth after three weeks when they received low -dose ASCs, combined with an energy strengthening molecule called adenosine triphosphate (ATP).

Hairstyles and medical experts confirm temporary hair loss affecting ozempic users

ASC treatments at low doses and high doses as well as ATP have led to any improvement in hair regrowth in women, but ASC at the middle dose plus ATP has resulted in greater regrowth.

The researchers concluded that hair regrowth was improved in “all experimental groups” where male mice received solutions of stem cells supplemented by ATP.

Researchers at the San Carlos clinical hospital in Madrid may have targeted a potential solution for hair loss. (istock)

The results were published in the journal Stem Cell Research & Therapy.

The author of the main study, Dr. Eduardo López Bran – dermatologist and professor at the compluten university of Madrid – shared his expectations for the study in an interview with Fox News Digital.

This daily beauty routine could ruin your hair, warn experts

“We expected good results, but not at such a high level of success,” he said. “We are talking about a very high degree of hair regrowth in male and feminine mice.”

With appropriate doses, the researchers have reached “very high percentages” of hair regrowth, noting that 100% of male mice and up to 90% of the female mice thank the hair.

With appropriate doses, the researchers have reached “very high percentages” of hair regrowth, noting that 100% of male mice and up to 90% of the female mice thank the hair. (Real mice of the unfulfilled study.) (istock)

“These results show that advanced therapies can represent a new therapeutic approach for many diseases for which no effective treatment is currently available,” continued Bran.

“Obtaining such promising results in the preclinical phase with a completely new approach to androgenetic alopecia – which avoids chronic treatment and is also safe – is a significant scientific step.”

“We are talking about a very high degree of hair regrowth in male and feminine mice.”

The main limitation of the study was the thinness of the skin of the mouse, noted Bran, who “posed a challenge in the administration of therapy”.

Click here to obtain the Fox News app

“This required the development of protocols to minimize experimental variability and will be a key factor when human studies start,” he said.

“Research advances point to possible solutions which, in the future, can offer sustainable results without the need for continuous treatment to maintain advantages.” (istock)

These new conclusions should be “interpreted with prudence and scientific rigor”, warned Bran.

“Although the results in mice represent significant progress, it is also true that it is essential to wait for clinical advantages in humans to be confirmed.”

Click here to register for our Health Newsletter

The researcher encouraged people with androgenetic alopecia to continue consulting their dermatologists and following prescribed treatments as research develops.

“It is important to keep hope. Research advances point to possible solutions which, in the future, can offer lasting results without the need for continuous treatment to maintain the advantages,” added Bran.

“This study is small and additional research is necessary on this method as a potential treatment option.”

In the order of human clinical trials, researchers “actively work” in confirmation of the security of men and women between 18 and 50 years old with moderate androgenetic alopecia, the researcher noted.

“If everything progresses as expected, the most optimistic calendar indicates that the treatment is available in about five years,” he said.

Pending human clinical trials, researchers “actively work” in confirmation of the security of men and women between 18 and 50 years old with moderate androgenetic alopecia. (istock)

In a separate interview with Fox News Digital, Dr. Brendan Camp, MD, a New York -based dermatologist who was not involved in the study, commented the potential of this method.

“Although it is not available in trade, this study suggests that the injection of stem cells supplemented by ATP in the skin of the scalp could potentially encourage hair regrowth in people with androgenetic alopecia,” he reiterated.

For more health items, visit www.foxnews.com/health.

“This study is small and additional research is necessary on this method as a potential treatment option for androgenetic alopecia.”

Until then, Camp encourages people to focus on the treatments currently available and “well studied” to combat hair loss and to visit a dermatologist certified by the board of directors for the evaluation.